Advertisement
Physician's Briefing Weekly Coronavirus Roundup

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
ASH: Daratumumab + Pomalidomide

ACAAI: Reaction to COVID-19 Vaccine Unlikely for Those With Common Allergies

0

Pfizer COVID-19 vaccine should not be administered to individuals with a known history of severe reaction to polyethylene glycol

Preconception Paternal Health Linked to Pregnancy Loss

0

Risk for pregnancy loss increases for men with one, two, three or more versus no components of metabolic syndrome

HealthDay Reports: Evidence Mounts That TB Vaccine Might Help Protect Against COVID-19

High-Income Countries Have Secured COVID-19 Vaccine Supplies

0

Up to 40 percent of vaccine courses from manufacturers might remain for low- and middle-income countries by end of 2021

Burden of Pre-  Postmenopausal Breast Cancer Up Worldwide
Purdue Pharma Pleads Guilty Over Role in U.S. Opioid Epidemic

Little Change Seen in Rx of Opioids for Those at Risk for Misuse

0

After CDC guideline publication, there was a 14 percent decrease in oxycodone prescriptions, but not for other Schedule II opioids

Pregnancy-Related Cardiovascular Outcomes Worse for Black Women

0

Compared with Whites, Black women had increased odds of mortality, myocardial infarction, stroke, PE, peripartum cardiomyopathy

SABCS: Adverse Effects of Breast RT Under-Recognized

0

Under-recognition of at least one of four symptoms occurred at least once for 53.2 percent of patients reporting symptoms

B 12/4 - High Blood Sugar Ups COVID Risks

Age at T2DM Diagnosis Inversely Linked to Risk for Adverse Outcomes

0

One-year increase in age at diabetes diagnosis linked to lower risk for all-cause mortality and macrovascular, microvascular disease

HealthDay Reports: Most Americans

U.S. COVID-19 Death Toll Hits 300,000 as Vaccine Rollout Begins

0

And, later this week, Moderna vaccine expected to receive recommendation from FDA advisory panel